Can Wegovy Make You Bleed? What Patients and Prescribers Actually See

Step 1: Check what Wegovy's licensed safety profile actually covers

The starting point for any safety question like this is the medicine's official UK prescribing information. Semaglutide's safety profile, as reflected on the NHS medicines page for semaglutide, centres predominantly on gastrointestinal effects: nausea, vomiting, diarrhoea, constipation, indigestion, burping and fatigue are the most frequently reported. Injection-site reactions, headache and dizziness also appear. Bleeding, in any straightforward sense, is not a listed common adverse effect.

This matters because the STEP 1 trial, which studied semaglutide 2.4mg over 68 weeks in nearly 2,000 adults, collected safety data rigorously. A signal of direct bleeding risk did not emerge from that dataset. So if you have read something online suggesting Wegovy causes bleeding as a routine effect, that does not reflect the current clinical evidence. If you are curious about the broader side-effect picture, our Wegovy overview page covers the full profile in detail.

None of this means every symptom is irrelevant. It means bleeding is not a pharmacological action of semaglutide, which is different from saying it can never occur around the time someone takes it.

Step 2: Understand the GI side effects that can sometimes look like bleeding

Here is where the nuance matters most. GLP-1 medicines slow gastric emptying and reduce appetite significantly. In the early weeks of treatment, or after a dose increase, nausea and vomiting can be quite pronounced. Forceful or repeated vomiting can irritate the oesophagus or cause small tears (a condition known as a Mallory-Weiss tear) producing traces of blood in vomit. This is a consequence of the vomiting itself, not a direct toxic effect of the drug, but it still needs medical evaluation.

Similarly, diarrhoea that is severe enough to cause rectal irritation may occasionally produce minor streaks of blood. Again, this is a mechanical consequence of GI distress rather than evidence that semaglutide targets blood vessels. The practical takeaway is the same either way: blood in vomit or stool while on any treatment is a reason to speak to your GP or prescriber, not something to wait out. The dedicated page on bleeding on Wegovy explores this distinction further.

Staying well hydrated during GI side effects is important. Many people keep their pen in the fridge door and forget that the stomach effects, not the injection itself, are the thing most likely to cause secondary discomfort in the first weeks.

Step 3: Consider menstrual changes separately from a bleeding risk

A number of women report changes to their menstrual cycle after starting Wegovy. Periods may become irregular, heavier or lighter. This is not because semaglutide directly affects the uterus or coagulation; current evidence suggests these changes are more likely related to the hormonal effects of significant weight loss itself. Fat tissue produces oestrogen, and as body weight changes, the hormonal environment shifts. Irregular cycles are a known consequence of rapid weight change, whether from any cause.

If you are asking specifically about nose bleeds, there is a separate question worth exploring. Our page on whether Wegovy can cause nose bleeds covers what the evidence says there. For questions about other unexpected effects, including vision changes sometimes reported by patients, it is always worth reading the Patient Information Leaflet carefully and raising concerns with your prescriber.

The MHRA's Yellow Card scheme lets anyone report a suspected side effect directly at yellowcard.mhra.gov.uk — it is a useful route if you experience something unexpected and want it formally recorded, regardless of whether a clear causal link has been established.

When to get medical help

Some symptoms should not wait for your next scheduled review. Get urgent medical attention if you notice: blood in vomit (which may look red or like coffee grounds); black, tarry or blood-streaked stools; severe abdominal pain that radiates to the back (which can be a sign of pancreatitis, a rare but serious risk the MHRA has highlighted for GLP-1 medicines); signs of significant dehydration from vomiting or diarrhoea; or any allergic reaction such as facial swelling, difficulty breathing or a widespread rash.

Heavy or unexpected menstrual bleeding that is new, prolonged or accompanied by pain should also be discussed with a GP, even if it seems unrelated to Wegovy. A prescriber can help you work out what needs investigation and what is likely self-limiting.

If you are weighing up Wegovy against other options or want to understand the full cost picture before starting, our Wegovy price comparison page sets out how private treatment is typically structured in the UK. For a broader look at the available weight-loss treatment options, that page covers the licensed medicines and how they differ. When you are ready to ask these questions of a real prescriber, you can start your free consultation with the nume clinical team, who review every case personally the same day it is submitted. If you have come across compounded versions and wondered whether semaglutide can actually be made outside a licensed manufacturer, that page explains what the regulations say.